Squarepoint Ops LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$704,347
+56.1%
77,231
+81.1%
0.00%
+100.0%
Q2 2023$451,121
+116.7%
42,639
+150.5%
0.00%0.0%
Q1 2023$208,204
-70.1%
17,024
-69.7%
0.00%
-66.7%
Q4 2022$696,511
-34.1%
56,125
-27.5%
0.00%
-40.0%
Q3 2022$1,057,000
+70.5%
77,399
+128.9%
0.01%
+66.7%
Q2 2022$620,000
+10.3%
33,817
-15.7%
0.00%
+200.0%
Q4 2021$562,000
-31.5%
40,119
+2.1%
0.00%
-66.7%
Q2 2021$820,000
-36.1%
39,310
-13.5%
0.00%
-62.5%
Q1 2021$1,284,000
+10.3%
45,429
+27.5%
0.01%
-11.1%
Q4 2020$1,164,000
+70.4%
35,635
+59.9%
0.01%0.0%
Q3 2020$683,000
-20.9%
22,292
-58.0%
0.01%
-35.7%
Q2 2020$864,000
-5.2%
53,023
-42.1%
0.01%
-39.1%
Q1 2020$911,000
-48.7%
91,591
-29.1%
0.02%
+109.1%
Q4 2019$1,777,000
+42.3%
129,237
+56.9%
0.01%0.0%
Q3 2019$1,249,000
+156.5%
82,359
+232.8%
0.01%
+120.0%
Q2 2019$487,000
+179.9%
24,744
+135.7%
0.01%
+150.0%
Q1 2019$174,000
-77.4%
10,496
-80.8%
0.00%
-77.8%
Q4 2018$769,000
-31.3%
54,796
-14.3%
0.01%
-30.8%
Q3 2018$1,119,000
+78.8%
63,920
+85.8%
0.01%
+62.5%
Q2 2018$626,000
+89.1%
34,400
+94.6%
0.01%
+60.0%
Q1 2018$331,000
+88.1%
17,677
+54.0%
0.01%
+66.7%
Q4 2017$176,000
-10.2%
11,478
-48.6%
0.00%
-40.0%
Q1 2017$196,000
+164.9%
22,318
+78.3%
0.01%
+66.7%
Q4 2016$74,00012,5180.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders